Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

DiaMedica Therapeutics (DMAC)

DiaMedica Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:DMAC
DateTimeSourceHeadlineSymbolCompany
24/05/202421:01Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:DMACDiaMedica Therapeutics Inc
23/05/202421:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DMACDiaMedica Therapeutics Inc
08/05/202421:34Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:DMACDiaMedica Therapeutics Inc
08/05/202421:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DMACDiaMedica Therapeutics Inc
08/05/202421:30Business WireDiaMedica Therapeutics Provides a Business Update and Announces First Quarter 2024 Financial ResultsNASDAQ:DMACDiaMedica Therapeutics Inc
02/05/202413:55Business WireDiaMedica Therapeutics to Report First Quarter 2024 Financial Results and Provide a Business Update May 9, 2024NASDAQ:DMACDiaMedica Therapeutics Inc
17/04/202421:08Business WireDiaMedica Therapeutics Announces First Patient Dosed in Relaunch of its Pivotal Phase 2/3 ReMEDy2 Trial of DM199 for the Treatment of Acute Ischemic StrokeNASDAQ:DMACDiaMedica Therapeutics Inc
19/03/202420:15Business WireDiaMedica Therapeutics Provides a Business Update and Announces Full Year 2023 Financial ResultsNASDAQ:DMACDiaMedica Therapeutics Inc
29/01/202421:13Business WireDiaMedica Therapeutics Announces Poster Presentation at International Stroke ConferenceNASDAQ:DMACDiaMedica Therapeutics Inc
23/01/202421:23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DMACDiaMedica Therapeutics Inc
23/01/202421:12Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:DMACDiaMedica Therapeutics Inc
22/01/202413:23Business WireDiaMedica Therapeutics Appoints Dr. Lorianne Masuoka as Chief Medical OfficerNASDAQ:DMACDiaMedica Therapeutics Inc
02/01/202422:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DMACDiaMedica Therapeutics Inc
02/01/202421:47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DMACDiaMedica Therapeutics Inc
02/01/202421:39Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DMACDiaMedica Therapeutics Inc
02/01/202421:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DMACDiaMedica Therapeutics Inc
16/11/202321:37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DMACDiaMedica Therapeutics Inc
13/11/202321:55Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:DMACDiaMedica Therapeutics Inc
13/11/202321:52Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DMACDiaMedica Therapeutics Inc
13/11/202321:28Business WireDiaMedica Therapeutics Provides a Business Update and Announces Third Quarter 2023 Financial ResultsNASDAQ:DMACDiaMedica Therapeutics Inc
09/11/202313:25Business WireDiaMedica Therapeutics to Attend the 14th Annual Craig-Hallum Alpha Select Conference November 16, 2023NASDAQ:DMACDiaMedica Therapeutics Inc
06/11/202313:23Business WireDiaMedica Therapeutics to Report Third Quarter 2023 Financial Results and Provide a Business Update November 14, 2023NASDAQ:DMACDiaMedica Therapeutics Inc
12/09/202313:13Business WireDiaMedica Therapeutics Announces the Appointment of Ambarish Shah, Ph.D. as Chief Technology OfficerNASDAQ:DMACDiaMedica Therapeutics Inc
06/09/202313:35Business WireDiaMedica Therapeutics to Participate at Lake Street’s 7th Annual Best Ideas Growth ConferenceNASDAQ:DMACDiaMedica Therapeutics Inc
05/09/202321:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DMACDiaMedica Therapeutics Inc
14/08/202321:29Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:DMACDiaMedica Therapeutics Inc
14/08/202321:25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DMACDiaMedica Therapeutics Inc
14/08/202321:13Business WireDiaMedica Therapeutics Provides a Business Update and Announces Second Quarter 2023 Financial ResultsNASDAQ:DMACDiaMedica Therapeutics Inc
08/08/202313:32Business WireDiaMedica Therapeutics to Report Second Quarter 2023 Financial Results and Provide a Business Update August 15, 2023NASDAQ:DMACDiaMedica Therapeutics Inc
18/07/202313:30Business WireDiaMedica Therapeutics to Attend the American Academy of Neurology Summer ConferenceNASDAQ:DMACDiaMedica Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:DMAC